The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
A Targeting Modality for Destruction of RNA Polymerase I that Possesses Anticancer Activity
Open accessAbstract
SUMMARY We define here the activity and mechanisms of action of a small molecule lead compound for cancer targeting. We show that the compound, BMH-21, has wide and potent antitumorigenic activity across NCI60 cancer cell lines and represses tumor growth in vivo. BMH-21 binds GC-rich sequences, which is present at high frequency in ribosomal DNA genes, and potently and rapidly represses RNA polymerase I (Pol I) transcription. Strikingly, we find that BMH-21 causes proteasome-dependent destruction of RPA194, the large catalytic subunit protein of Pol I holocomplex, and this correlates with cancer cell killing. Our results show that Pol I activity is under proteasome-mediated control, which reveals an unexpected therapeutic opportunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · cited 1×
“Specifically, the cancer genome mutational analyses pinpointed pathways that are frequently deregulated and highlighted key mutational events based on which new therapeutic molecules have been successfully devised (Stratton, 2011; Vogelstein et al., 2013).”
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1951 · Cited by 2,620
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Andersen, J. S., Lam, Y. W., Leung, A. K. L., Ong, S.-E., Lyon, C. E., Lamond, A. I., & Mann, M. (2005) · Nature · doi:10.1038/nature03207 · Cited by 1,149
Boulon, S., Westman, B. J., Hutten, S., Boisvert, F.-M., & Lamond, A. I. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.024 · Cited by 1,103
Does the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1015 · Cited by 928
Rubbi, C. P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg579 · Cited by 811
Exploring the Genomes of Cancer Cells: Progress and Promise
Stratton, M. R. (2011) · Science · doi:10.1126/science.1204040 · Cited by 693
Drygin, D., Lin, A., Bliesath, J., Ho, C. B., O'Brien, S. E., Proffitt, C., Omori, M., Haddach, M., Schwaebe, M. K., Siddiqui-Jain, A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1728 · Cited by 618
Signaling to p53: ribosomal proteins find their way
Zhang, Y., & Lu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.024 · Cited by 591
Bywater, M. J., Poortinga, G., Sanij, E., Hein, N., Peck, A., Cullinane, C., Wall, M., Cluse, L., Drygin, D., Anderes, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.019 · Cited by 563
The Epigenetics of rRNA Genes: From Molecular to Chromosome Biology
McStay, B., & Grummt, I. (2008) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.24.110707.175259 · Cited by 526
Mayer, C., Zhao, J., Yuan, X., & Grummt, I. (2004) · Genes & Development · doi:10.1101/gad.285504 · Cited by 505
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription
Arabi, A., Wu, S., Ridderstråle, K., Bierhoff, H., Shiue, C., Fatyol, K., Fahlén, S., Hydbring, P., Söderberg, O., Grummt, I., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1225 · Cited by 472
Hager, G. L., McNally, J. G., & Misteli, T. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.005 · Cited by 461
Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels
Burger, K., Mühl, B., Harasim, T., Rohrmoser, M., Malamoussi, A., Orban, M., Kellner, M., Gruber-Eber, A., Kremmer, E., Hölzel, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074211 · Cited by 458
Pederson, T. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000638 · Cited by 455
Nucleolus, Ribosomes, and Cancer
Montanaro, L., Treré, D., & Derenzini, M. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070752 · Cited by 451
Fatica, A., & Tollervey, D. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00336-8 · Cited by 446
Kurki, S., Peltonen, K., Latonen, L., Kiviharju, T. M., Ojala, P. M., Meek, D., & Laiho, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00110-2 · Cited by 416
Self-citationActivity of RNA polymerase I transcription factor UBF blocked by Rb gene product
Cavanaugh, A. H., Hempel, W. M., Taylor, L. J., Rogalsky, V., Todorov, G., & Rothblum, L. I. (1995) · Nature · doi:10.1038/374177a0 · Cited by 334
Repression of RNA Polymerase I Transcription by the Tumor Suppressor p53
Zhai, W., & Comai, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5930-5938.2000 · Cited by 289 · cited 3×
“Nucleolar activities are increased in cancer, and mutations of nucleolar and ribosomal proteins drive tumorigenesis (Montanaro et al., 2008; Pederson, 2011; Ruggero and Pandolfi, 2003). rRNA synthesis is commonly deregulated in cancer, by overt activation by oncogenes, like Myc, Her2/Neu; growth factor signaling pathw…”
A Fluorescent Intercalator Displacement Assay for Establishing DNA Binding Selectivity and Affinity
Tse, W. C., & Boger, D. L. (2004) · Accounts of Chemical Research · doi:10.1021/ar030113y · Cited by 288
Abundance of Ribosomal RNA Gene Copies Maintains Genome Integrity
Ide, S., Miyazaki, T., Maki, H., & Kobayashi, T. (2010) · Science · doi:10.1126/science.1179044 · Cited by 287
Nucleolar Arf Tumor Suppressor Inhibits Ribosomal RNA Processing
Sugimoto, M., Kuo, M.-L., Roussel, M. F., & Sherr, C. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00057-1 · Cited by 273
Maclean, K. H., Dorsey, F. C., Cleveland, J. L., & Kastan, M. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33700 · Cited by 272
AKT Promotes rRNA Synthesis and Cooperates with c-MYC to Stimulate Ribosome Biogenesis in Cancer
Chan, J. C., Hannan, K. M., Riddell, K., Ng, P. Y., Peck, A., Lee, R. S., Hung, S., Astle, M. V., Bywater, M., Wall, M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001754 · Cited by 239
Curaxins: Anticancer Compounds That Simultaneously Suppress NF-κB and Activate p53 by Targeting FACT
Gasparian, A. V., Burkhart, C. A., Purmal, A. A., Brodsky, L., Pal, M., Saranadasa, M., Bosykh, D. A., Commane, M., Guryanova, O. A., Pal, S., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002530 · Cited by 237
AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply
Hoppe, S., Bierhoff, H., Cado, I., Weber, A., Tiebe, M., Grummt, I., & Voit, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909873106 · Cited by 225
Dysregulation of the basal RNA polymerase transcription apparatus in cancer
Bywater, M. J., Pearson, R. B., McArthur, G. A., & Hannan, R. D. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3496 · Cited by 222
Inhibiting the transcription factor HSF1 as an anticancer strategy
Whitesell, L., & Lindquist, S. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902832697 · Cited by 222
Functional Architecture of RNA Polymerase I
Kuhn, C.-D., Geiger, S. R., Baumli, S., Gartmann, M., Gerber, J., Jennebach, S., Mielke, T., Tschochner, H., Beckmann, R., & Cramer, P. (2007) · Cell · doi:10.1016/j.cell.2007.10.051 · Cited by 214
Ubiquitylation and degradation of elongating RNA polymerase II: The last resort
Wilson, M. D., Harreman, M., & Svejstrup, J. Q. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.08.002 · Cited by 194
A role for c-Myc in the regulation of ribosomal RNA processing
Schlosser, I. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg794 · Cited by 182
The RNA polymerase I transcription machinery
Russell, J., & Zomerdijk, J. C. B. M. (2006) · Biochemical Society Symposia · doi:10.1042/bss0730203 · Cited by 177
Nucleolus: from structure to dynamics
Hernandez-Verdun, D. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0046-4 · Cited by 177
Merz, K., Hondele, M., Goetze, H., Gmelch, K., Stoeckl, U., & Griesenbeck, J. (2008) · Genes & Development · doi:10.1101/gad.466908 · Cited by 176
Regulation of ribosome biogenesis within the nucleolus
Leary, D. J., & Huang, S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03143-x · Cited by 160
p53 represses ribosomal gene transcription
Budde, A., & Grummt, I. (1999) · Oncogene · doi:10.1038/sj.onc.1202402 · Cited by 157
Moore, H. M., Bai, B., Boisvert, F., Latonen, L., Rantanen, V., Simpson, J. C., Pepperkok, R., Lamond, A. I., & Laiho, M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.009241 · Cited by 147
Self-citationThe role of UBF in regulating the structure and dynamics of transcriptionally active rDNA chromatin
Sanij, E., & Hannan, R. D. (2009) · Epigenetics · doi:10.4161/epi.4.6.9449 · Cited by 129
Grummt, I. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07892.x · Cited by 113
Peltonen, K., Colis, L. C., Liu, H., Jäämaa, S., Moore, H. M., Enbäck, J., Laakkonen, P., Vaahtokari, A., Jones, R. J., af Hällström, T. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012996 · Cited by 107
Self-citationFrench, S. L., Sikes, M. L., Hontz, R. D., Osheim, Y. N., Lambert, T. E., Hage, A. E., Smith, M. M., Tollervey, D. W., Smith, J. S., & Beyer, A. L. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00589-10 · Cited by 102
Ghoshal, K., & Jacob, S. T. (1994) · PubMed · Cited by 101
Li, L., Chen, H., Hsieh, Y., Wang, Y., Chu, H.-J., Chen, Y.-H., Chen, H., Chien, P., Ma, H.-T., Tsai, H.-C., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3504 · Cited by 96
Modulation of RNA Polymerase Assembly Dynamics in Transcriptional Regulation
Gorski, S. A., Snyder, S. K., John, S., Grummt, I., & Misteli, T. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.021 · Cited by 96
Establishment and Maintenance of Alternative Chromatin States at a Multicopy Gene Locus
Wittner, M., Hamperl, S., Stöckl, U., Seufert, W., Tschochner, H., Milkereit, P., & Griesenbeck, J. (2011) · Cell · doi:10.1016/j.cell.2011.03.051 · Cited by 95
Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36
Endo, A., Matsumoto, M., Inada, T., Yamamoto, A., Nakayama, K. I., Kitamura, N., & Komada, M. (2009) · Journal of Cell Science · doi:10.1242/jcs.044461 · Cited by 90
A Conserved Deubiquitinating Enzyme Controls Cell Growth by Regulating RNA Polymerase I Stability
Richardson, L. A., Reed, B. J., Charette, J. M., Freed, E. F., Fredrickson, E. K., Locke, M. N., Baserga, S. J., & Gardner, R. G. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.07.009 · Cited by 68
A model for the topology of active ribosomal RNA genes
Denissov, S., Lessard, F., Mayer, C., Stefanovsky, V., van Driel, M., Grummt, I., Moss, T., & Stunnenberg, H. G. (2011) · The EMBO Reports · doi:10.1038/embor.2011.8 · Cited by 58 · cited 2×
“Topologically, the rDNA transcription may take place around a centrally located initiation core surrounded by a helical cylinder of the elongating Pol I complexes (Denissov et al., 2011).”
Mass Spectrometry Reveals Stable Modules in holo and apo RNA Polymerases I and III
Lane, L. A., Fernández‐Tornero, C., Zhou, M., Morgner, N., Ptchelkine, D., Steuerwald, U., Politis, A., Lindner, D., Gvozdenović, J., Gavin, A., et al. (2011) · Structure · doi:10.1016/j.str.2010.11.009 · Cited by 52
Mechanism of RNA Polymerase I Transcription
Comai, L. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)67005-7 · Cited by 35
Preparation of Synchronized Human Cell Extracts to Study Ubiquitination and Degradation
Williamson, A. P., Jin, L., & Rapé, M. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-993-2_19 · Cited by 24
RNA Polymerase I: A Multifunctional Molecular Machine
Haag, J. R., & Pikaard, C. S. (2007) · Cell · doi:10.1016/j.cell.2007.12.005 · Cited by 23
A Fluorescent Intercalator Displacement Assay for Establishing DNA Binding Selectivity and Affinity
Tse, W. C., & Boger, D. L. (2005) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0805s20 · Cited by 17
Cited by
Ribosome biogenesis in cancer: new players and therapeutic avenues
Pelletier, J., Thomas, G., & Volarević, S. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.104 · Cited by 812
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours
Xu, H., Di Antonio, M., McKinney, S., Mathew, V., Ho, B., O’Neil, N. J., Santos, N. D., Silvester, J., Wei, V., Garcia, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14432 · Cited by 580
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
Kang, J., Brajanovski, N., Chan, K. T., Xuan, J., Pearson, R. B., & Sanij, E. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00728-8 · Cited by 408
The cell proliferation antigen Ki-67 organises heterochromatin
Sobecki, M., Mrouj, K., Camasses, A., Parisis, N., Nicolas, E., Llères, D., Gerbe, F., Prieto, S., Krasinska, L., David, A., et al. (2016) · eLife · doi:10.7554/elife.13722 · Cited by 362
Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance
Elhamamsy, A. R., Metge, B. J., Alsheikh, H. A., Shevde, L. A., & Samant, R. S. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4087 · Cited by 300
Metadata
- Authors
- Peltonen, K., Colis, L., Liu, H., Trivedi, R., Moubarek, M. S., Moore, H. M., Bai, B., Rudek, M. A., Bieberich, C. J., & Laiho, M.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 25
- Issue
- 1
- Pages
- 77-90
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2033742799
- Cited by
- 314
- References
- 57
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.